echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > BMJ Sub-Journal: What are the signs of fat hypertrophy in patients with type 1 diabetes, and how should this degree of hypertrophy be evaluated?

    BMJ Sub-Journal: What are the signs of fat hypertrophy in patients with type 1 diabetes, and how should this degree of hypertrophy be evaluated?

    • Last Update: 2022-01-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Lipid hypertrophy is a common complication of insulin therapy
    .


    Despite the prevalence of fat hypertrophy and its potentially dangerous effects on blood sugar regulation, it is still a relatively unresearched problem in diabetes


    Lipid hypertrophy is a common complication of insulin therapy


    This observational study included 74 type 1 diabetic patients at the Diabetes Center in South East London
    .


    Participants' insulin-exposed areas were scanned ultrasound with a high-frequency linear probe (6-13 MHz)


    This observational study included 74 type 1 diabetic patients at the Diabetes Center in South East London


    The average age and duration of diabetes of the participants were 40.


    Grading characteristics of fat hypertrophy

    Grading characteristics of fat hypertrophy Grading characteristics of fat hypertrophy

    In 52 subjects (70%), the thickness of the dermis increased by 30% compared to locally uninjected tissue, while in 36 subjects (48%), the thickness of the dermis increased by 50%
    .


    The thickness of the abdomen of 22 (40%) subjects and the thigh of 8 (17.


    In 52 subjects (70%), the thickness of the dermis increased by 30% compared to locally uninjected tissue, while in 36 subjects (48%), the thickness of the dermis increased by 50%


    Conceptual model of fat hypertrophy

    Conceptual model of fat hypertrophy Conceptual model of fat hypertrophy

    This study shows that insulin-related tissue changes are heterogeneous in nature, including fatty hypertrophy and wider dermal and subcutaneous tissue changes
    .


    The researchers used these observations to establish a conceptual module and also developed an ultrasound grading tool for evaluating tissue changes to guide future research and clinical understanding


    This study shows that insulin-related tissue changes are heterogeneous in nature, including fatty hypertrophy and wider dermal and subcutaneous tissue changes


    References: Hashem R, Mulnier H, Abu Ghazaleh H, et al Characteristics and morphology of lipohypertrophic lesions in adults with type 1 diabetes with ultrasound screening: an exploratory observational study BMJ Open Diabetes Research and Care 2021;9:e002553.
    doi: 10.
    1136 /bmjdrc-2021-002553doi: 10.
    1136/bmjdrc-2021-002553 leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.